[go: up one dir, main page]

CH300198A - Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate. - Google Patents

Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate.

Info

Publication number
CH300198A
CH300198A CH300198DA CH300198A CH 300198 A CH300198 A CH 300198A CH 300198D A CH300198D A CH 300198DA CH 300198 A CH300198 A CH 300198A
Authority
CH
Switzerland
Prior art keywords
dimethyl
methyl
methylsulfate
benzhydrylidenepiperidine
preparing
Prior art date
Application number
Other languages
French (fr)
Inventor
Corporation Schering
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US242438A external-priority patent/US2739968A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of CH300198A publication Critical patent/CH300198A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  ,Procédé de préparation du     méthy1sulfate    de     2,6-diméthyl-N-méthyl-3-benzhydrylidènepipéridine.       La présente invention se rapporte à la pré  paration de composés     pipéridiniques    possédant  d'importantes propriétés physiologiques, anti  histaminiques, antispasmodiques,     antiaeétyl-          choliniques    et     analgésiques.     



  La brevetée a découvert que les composés  de     formule    générale  
EMI0001.0008     
    dans     laquelle    R et Ri sont des groupes aryle,       aralcoyle,        aralcényle,        eycloalcoyle,        cy        cloalcène,     hétérocyclique, alcoyle ou alcène, R2 est de  l'hydrogène ou un groupe alcoyle inférieur ou       aralcoyle,    R3 est de l'hydrogène, du chlore,  du brome ou un groupe alcoyle inférieur ou       alcoxy    inférieur et Y est de l'hydrogène ou  un groupe hydroxyle,     alcoxy    ou     acylozy,

      ou  une liaison additionnelle avec le noyau de la       pipéridine,    ont les propriétés susmentionnées.  On peut citer, à titre d'exemples représenta  tifs des groupes     R.    et     R1,    les radicaux     phé-          nyle,    benzyle,     benzal,        thiényle,        pyridyle,        pyri-          midyle,        thiazyle,        furyle,        cyclohexyle,        cyclo-          hexényle,    propyle,     isopropyle,

      butyle et autres,  éventuellement chlorés au bromés, les groupes       dialcoylamino,        alcoxy    inférieurs et alcoyles  inférieurs substitués. Particulièrement utiles    en médecine sont les composés de formule gé  nérale ci-dessus dans lesquels Y est de l'hydro  gène ou une liaison additionnelle avec le noyau  de la     pipéridine.    Les sels d'acides et les sels  quaternaires des composés de     la:    formule géné  rale indiquée ont les mêmes effets.

   D'une ma  nière générale, on améliore les activités     anti-          acétylcholiniques    et de blocage ganglionnaire  et parasympathique en formant les sels qua  ternaires tels que le     méthiodure,    le     méthochlo-          rure,    le     méthobromure,    le     méthosulfate,          l'éthiodure,    le     p-toluène-sulfonate,        @        etc.,    de  l'atome d'azote tertiaire.

   On a trouvé que les  sels quaternaires des composés de     pipéridyli-          dène    sont particulièrement précieux pour le  réglage des sécrétions gastriques, et de la  motilité ou motricité gastrique dans les cas       d'ulcères.    Indépendamment. des sels quater  naires se sont également montrés efficaces les  sels d'addition avec les acides     tels    que les  chlorhydrate, tartrate,     maléate,    citrate et sali  cylate des composés     pipéridiniques    de la for  mule générale indiquée.

       Ces    sels sont     parti-          eulièrement    intéressants dans les cas où les  amines doivent être utilisées en solution.  



  Le présent brevet a pour objet un procédé  de préparation     d'Un    de ces composés, savoir  le     méthylsulfate    de     2,6-diméthyl-N-méthyl-3-          benzhydrvlidènepipéridine,    qui est une subs  tance nouvelle.

   Ce procédé est caractérisé en  ce qu'on fait réagir le     2,6-diméthyl-N-méthyl-          3-pipéridyldiphénylcarbinol    avec un agent  déshydratant de façon à obtenir la 2,6-dimé-           thyl-N-méthyl-3-benzhydrylidènepipéridine    et  qu'on traite cette dernière avec du sulfate       diméthylique    pour former le     méthylsulfate     de     2,6-diméthyl-N-méthyl-3-benzhydrylidène-          pipéridine.     



  <I>Exempte:</I>  Le 2,     6-diméthyl    - N -     méthy        1-3-pipéridyldi-          phénylcarbinol    de départ a. été préparé comme  suit:  Une solution de 35 g de     2,6-diméthylnico-          tinate    d'éthyle et de 50 g de     p-toluène-sulfo-          nate    de méthyle est chauffée pendant 4 heures  au bain de vapeur. Par dilution de l'huile  épaisse au moyen de benzène, on obtient le sel  quaternaire correspondant sous forme d'un  solide blanc; point de fusion 90-91  C. On  dissout ce sel dans de l'éthanol absolu et ré  duit dans un appareil de Parr au moyen  d'hydrogène et d'oxyde de platine.

   On sépare  le catalyseur par filtration, le filtrat est coi  centré     dans    le vide et le résidu     dissous    dans de  l'eau. Le filtrat aqueux est rendu basique avec  du carbonate de potassium, la couche huileuse  étant     extraite    avec de l'éther, l'éther est séché  et concentré, le résidu, c'est-à-dire le     2,6-di-          méthyl-N-méthylnipécotate    d'éthyle, étant frac  tionné et présentant un point d'ébullition de  102-107  C sous 1     mm.     



  L'éther-sel ainsi obtenu est     transformé    en  2,6 -     diméthyT-N-méthyl-3        -pipéridyldiphényl-          carbinol    de la manière suivante: A une solu  tion de Grignard, préparée avec 12 g de ma  gnésium et 80 g de     bromo-benzène,    on ajoute  22 g de 2,6 -     diméthyl    - N -     méthylnipécotate     d'éthyle. Le mélange de réaction est agité et  on laisse refluer pendant dix heures, on le dé  compose au moyen d'acide chlorhydrique; le  chlorhydrate     est    ensuite filtré.

   Le     chlor-          hydrate    est laissé en suspension dans de l'eau  chaude et traité avec 50  /a d'hydrate de so  dium, la base libre étant extraite avec du ben  zène.  



  Les extraits benzéniques sont séchés, con  centrés, le résidu     huileux    devenant solide lors    du     refroidissement    (point de fusion 162 à  163  C). Le     carbinol    est déshydraté de la  façon     ci-après:     Un mélange de 16 g du     carbinol    et 200  millilitres d'acide sulfurique à 40     1/o    est agité  et chauffé au bain de vapeur pendant 10 heures.  



  La solution     est    versée sur de la glace, ren  due basique avec 50 %     d'hydroxyde    de sodium,  la couche huileuse étant     ensuite    extraite avec  de l'éther.     Les        extraits    éthérés sont séchés, con  centrés, l'huile résiduelle étant fractionnée.  On obtient la     2,6-diméthyl-N-méthyl-3-benz-          hydrylidènepipéridine,    point d'ébullition 152  à 157  C/1 mm.  



  Le sel quaternaire est obtenu comme suit:  Une solution de 0,1 mole du composé     pi-          péridylidénique,    de 0,1 mole de sulfate     dimé-          thylique    et de 50 millilitres d'acétone est lais  sée refluer pendant 5-10 minutes.  



  Après avoir laissé refroidir et avoir dilué  à l'éther, on obtient le     méthylsulfate    de     2,6-          diméth-#-1-N        méthyl-3-benzhydrylidènepipéri-          dine,    point de fusion 153-154  C,     recristalli-          sable    au sein d'éther et d'acétone.



  , Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate. The present invention relates to the preparation of piperidinic compounds having important physiological, antihistamine, antispasmodic, anti-etylcholinic and analgesic properties.



  The patentee discovered that compounds of the general formula
EMI0001.0008
    where R and R 1 are aryl, aralkyl, aralkenyl, eycloalkyl, cy cloalkene, heterocyclic, alkyl or alkene, R2 is hydrogen or a lower alkyl or aralkyl group, R3 is hydrogen, chlorine, bromine or a lower alkyl or lower alkoxy group and Y is hydrogen or a hydroxyl, alkoxy or acylozy group,

      or an additional bond with the piperidine core, have the aforementioned properties. Mention may be made, by way of representative examples of the groups R. and R1, the phenyl, benzyl, benzal, thienyl, pyridyl, pyridimidyl, thiazyl, furyl, cyclohexyl, cyclohexenyl, propyl, isopropyl,

      butyl and others, optionally chlorinated with brominated, dialkylamino, lower alkoxy and substituted lower alkyl groups. Particularly useful in medicine are the compounds of the general formula above in which Y is hydrogen or an additional bond with the core of piperidine. Acid salts and quaternary salts of compounds of the general formula given have the same effects.

   In general, the anti-acetylcholinic and ganglionic and parasympathetic blocking activities are improved by forming qua ternary salts such as methiodide, methochloride, methobromide, methosulfate, ethiodide, p-toluene. -sulfonate, etc., of the tertiary nitrogen atom.

   The quaternary salts of the piperidylidene compounds have been found to be particularly valuable for the control of gastric secretions, and gastric motility or motility in ulcers. Independently. quaternary salts have also been shown to be effective addition salts with acids such as hydrochloride, tartrate, maleate, citrate and salt of piperidine compounds of the general formula indicated.

       These salts are particularly useful in cases where the amines are to be used in solution.



  The subject of the present patent is a process for preparing one of these compounds, namely 2,6-dimethyl-N-methyl-3-benzhydrvlidenepiperidine methylsulfate, which is a new substance.

   This process is characterized in that 2,6-dimethyl-N-methyl-3-piperidyldiphenylcarbinol is reacted with a dehydrating agent so as to obtain 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine and the latter is treated with dimethyl sulfate to form 2,6-dimethyl-N-methyl-3-benzhydrylidene-piperidine methylsulfate.



  <I> Free: </I> The starting 2, 6-dimethyl - N - methyl 1-3-piperidyldi-phenylcarbinol a. was prepared as follows: A solution of 35 g of ethyl 2,6-dimethylnicotinate and 50 g of methyl p-toluenesulfonate is heated for 4 hours in a steam bath. By diluting the thick oil with benzene, the corresponding quaternary salt is obtained in the form of a white solid; melting point 90-91 C. This salt is dissolved in absolute ethanol and reduced in a Parr apparatus with hydrogen and platinum oxide.

   The catalyst is filtered off, the filtrate is centered in vacuo and the residue dissolved in water. The aqueous filtrate is made basic with potassium carbonate, the oily layer being extracted with ether, the ether is dried and concentrated, the residue, i.e. 2,6-dimethyl- Ethyl N-methylnipecotate, being fractionated and having a boiling point of 102-107 C under 1 mm.



  The ether-salt thus obtained is converted into 2,6 - dimethylT-N-methyl-3 -piperidyldiphenyl-carbinol as follows: To a Grignard solution, prepared with 12 g of magnesium and 80 g of bromo- benzene, 22 g of ethyl 2,6 - dimethyl - N - methylnipecotate are added. The reaction mixture is stirred and allowed to reflux for ten hours, decomposed using hydrochloric acid; the hydrochloride is then filtered.

   The hydrochloride is left in suspension in hot water and treated with 50 µl of sodium hydrate, the free base being extracted with benzene.



  The benzene extracts are dried, concentrated, the oily residue becoming solid on cooling (melting point 162 to 163 C). The carbinol is dehydrated as follows: A mixture of 16 g of the carbinol and 200 milliliters of 40 1 / o sulfuric acid is stirred and heated in a steam bath for 10 hours.



  The solution is poured onto ice, made basic with 50% sodium hydroxide, the oily layer then being extracted with ether. The ethereal extracts are dried, concentrated, the residual oil being fractionated. 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine, boiling point 152-157 C / 1 mm is obtained.



  The quaternary salt is obtained as follows: A solution of 0.1 mole of the peridylidene compound, 0.1 mole of dimethyl sulfate and 50 milliliters of acetone is allowed to reflux for 5-10 minutes.



  After leaving to cool and diluting with ether, 2,6- dimeth - # - 1-N methylsulfate is obtained methyl-3-benzhydrylidenepiperidine, melting point 153-154 C, recrystallizable from ether and acetone.

 

Claims (1)

REVENDICATION: Procédé de préparation du méthylsulfate de 2,6-diméthyl-N-méthyl-3-benzhydrylidène- pipéridine, caractérisé en ce qu'on fait réagir le 2,6-diméthyl-N-méthyl-3-pipéridyldiphényl- earbinol avec un agent. déshydratant de faon à obtenir la 2, CLAIM: Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidene-piperidine methylsulfate, characterized in that 2,6-dimethyl-N-methyl-3-piperidyldiphenyl-earbinol is reacted with a agent. desiccant so as to get the 2, 6-diméthy 1-N-méthy 1-3-benz- hy drylidènepipéridine et qu'on traite cette dernière avec du-sulfate diméthylique pour former le méthylsulfate de 2,6-diméthyl-\T- méth-#>I-3-benzhydrvlidènepipéridine. Le sel quaternaire ainsi obtenu est un so lide fondant à 153-154 C. SOUS-REVENDICATION: Procédé selon la revendication, caractérisé en ce qu'on emploie comme agent déshydra tant de l'acide sulfurique. 6-dimethyl 1-N-methyl 1-3-benz- hy drylidenepiperidine and treated with dimethyl sulfate to form 2,6-dimethyl- \ T-meth methylsulfate - #> I-3- benzhydrvlidenepiperidine. The quaternary salt thus obtained is a solid melting at 153-154 C. SUB-CLAIM: Process according to claim, characterized in that sulfuric acid is used as the dehydrating agent.
CH300198D 1950-12-05 1951-12-03 Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate. CH300198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US300198XA 1950-12-05 1950-12-05
US320589XA 1950-12-05 1950-12-05
US242438A US2739968A (en) 1950-12-05 1951-08-17 Substituted piperidines

Publications (1)

Publication Number Publication Date
CH300198A true CH300198A (en) 1954-07-15

Family

ID=27363577

Family Applications (1)

Application Number Title Priority Date Filing Date
CH300198D CH300198A (en) 1950-12-05 1951-12-03 Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate.

Country Status (1)

Country Link
CH (1) CH300198A (en)

Similar Documents

Publication Publication Date Title
US4711899A (en) 2-(4-benzoyl-1-piperidyl)-1-phenylalkanol derivatives
FR2670491A1 (en) NOVEL 1,4-DISUBSTITUTED PIPERAZINES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
JP2637737B2 (en) New drugs
LU86435A1 (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA1178589A (en) 2-(4-piperidyl)-1(4-quinolyl)-ethanone derivatives, process for preparing the same and their use as drugs
FR2557570A1 (en) NOVEL QUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
EP0002978A2 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
CH300198A (en) Process for preparing 2,6-dimethyl-N-methyl-3-benzhydrylidenepiperidine methylsulfate.
FR2495470A1 (en) NEW MEDICAMENTS BASED ON (QUINOLYL-4) -1 (PIPERIDYL-4) -2 ETHANOL OR (QUINOLYL-4) -1 (PIPERIDYL-4) -3 PROPANOL DERIVATIVES
CA1042905A (en) Preparation of new bisubstituted azabicycloalkans_
CH377356A (en) Process for the preparation of novel phenothiazine derivatives
US4022792A (en) Methylidenepiperidines
FR2475544A1 (en) NOVEL INDANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
BE1000112A5 (en) METHOD FOR PREPARING encainide.
US3184473A (en) Imidazoline derivatives
CA1044697A (en) Novel disubstituted azabicycloalcanes
EP0099822B1 (en) 1-(2-carbalkoxy-4-(thienylalkylamido)phenoxy)-3-amino-2-propanols, their preparation and their uses in therapy
CH421971A (en) Preparation of new derivatives of salicylic acid
US3976653A (en) 3-Piperidine-methanols
CH306511A (en) A process for preparing 1-methyl-3-piperidylmethyl 2-cyclopentyl-4-methylpentanoate.
JPH0418071A (en) Bispiperidine derivatives
CH385209A (en) Process for the preparation of new phenothiazines
BE533046A (en)
CH354081A (en) Process for the preparation of novel phenothiazinyl-10-carboxylic acid esters
CH299098A (en) Manufacturing process of 1-phenyl-1- (2-pyridyl) -3-dimethyl-aminopropane.